- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer ; volume:9 ; number:1 ; day:2 ; month:6 ; year:2017 ; pages:1-12 ; date:12.2017
Clinical epigenetics ; 9, Heft 1 (2.6.2017), 1-12, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Richter, Antje M.
- Beteiligte Personen und Organisationen
-
Kiehl, Steffen
Köger, Nicole
Breuer, Janina
Stiewe, Thorsten
Dammann, Reinhard
SpringerLink (Online service)
- DOI
-
10.1186/s13148-017-0360-4
- URN
-
urn:nbn:de:1111-2017070110521
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Richter, Antje M.
- Kiehl, Steffen
- Köger, Nicole
- Breuer, Janina
- Stiewe, Thorsten
- Dammann, Reinhard
- SpringerLink (Online service)
Ähnliche Objekte (12)
The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomas
The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth
The tumor suppressive mir-148a is epigenetically inactivated in classical Hodgkin lymphoma
Understanding p53 tumour suppressor network
Understanding p53 tumour suppressor network
Regulation of the NF2 tumour suppressor Merlin
Dexmedetomidine expands monocytic myeloid-derived suppressor cells and promotes tumour metastasis after lung cancer surgery
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS
ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration
Degradation of tumour suppressor ρ53 during Chlamydia trachomatis infections
Degradation of Tumour Suppressor p53 during Chlamydia trachomatis Infections
The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomas
The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth
The tumor suppressive mir-148a is epigenetically inactivated in classical Hodgkin lymphoma
Understanding p53 tumour suppressor network
Understanding p53 tumour suppressor network
Regulation of the NF2 tumour suppressor Merlin
Dexmedetomidine expands monocytic myeloid-derived suppressor cells and promotes tumour metastasis after lung cancer surgery
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS
ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration
Degradation of tumour suppressor ρ53 during Chlamydia trachomatis infections
Degradation of Tumour Suppressor p53 during Chlamydia trachomatis Infections
The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomas
The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth
The tumor suppressive mir-148a is epigenetically inactivated in classical Hodgkin lymphoma
Understanding p53 tumour suppressor network
Understanding p53 tumour suppressor network
Regulation of the NF2 tumour suppressor Merlin
Dexmedetomidine expands monocytic myeloid-derived suppressor cells and promotes tumour metastasis after lung cancer surgery
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS
ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration
Degradation of tumour suppressor ρ53 during Chlamydia trachomatis infections